General Updates

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai 400 093, India W www.ajantapharma.com 30th July 2026 BSE LIMITED National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. Dalal Street, C/1, G Block, Bandra Kurla Complex, Mumbai – 400001 Bandra (East), Mumbai – 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Sub.: Reg. 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, This is to inform that the Nomination & Remuneration Committee of the Board has at its meeting held today Allotted 23,400 fully paid-up equity shares of Rs. 2/- each issued upon exercise of options. In view of the above, the paid-up capital of the Company stands increased to Rs. 24,99,18,048 consisting of 12,49,59,024 equity shares of Rs. 2/- each. Company will be making application for listing of these shares in due course. This is for your information and record. Thanking You, Yours faithfully, GAURANG SHAH Sr. VP - Legal & Company Secretary Corporate Identity Number - L24230MH1979PLC022059